trending Market Intelligence /marketintelligence/en/news-insights/trending/_S5QlawEkmDbrA7lNRXzog2 content esgSubNav
In This List

Phosphagenics to sell BioElixia brand

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Phosphagenics to sell BioElixia brand

Phosphagenics Ltd. agreed to sell its global BioElixia beauty brand to Pure Beauty Australia Pty Ltd., a unit of private investment group CEM Group of Companies.

The deal will allow Pure Beauty to market and expand the BioElixia range, which comprises products that contain Phosphagenics' proprietary drug delivery system called targeted penetration matrix, or TPM. The sale is in line with Phosphagenics' strategic decision to focus on core TPM businesses.

Phosphagenics will receive a A$200,000 up-front payment, ongoing royalties of 5% based on net sales of products containing TPM and payments from an associated 10-year TPM supply agreement.

The transaction is expected to close the week of Aug. 14.

As of Aug. 9, US$1 was equivalent to A$1.27.